Perfusion and diffusion MRI combined with 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas

Journal of Neuro-Oncology

Volumn 114, Issue 2, 2013, Pages 241-249

  Berntsson, Shala Ghaderi ^a   Falk, Anna ^b   Savitcheva, Irina ^a   Godau, Andrea ^b   Zetterling, Maria ^b   Hesselager, Göran ^b   Alafuzoff, Irina ^b   Larsson, Elna Marie ^b   Smits, Anja ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

11C methionine (MET); Diffusion MRI; Low grade gliomas; Perfusion MRI; Positron emission tomography (PET); Preoperative evaluation

Indexed keywords

METHIONINE C 11; CARBON; METHIONINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CANCER GRADING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PERFUSION WEIGHTED IMAGING; PET SCANNER; PICTURE ARCHIVING AND COMMUNICATION SYSTEM; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME; AUTOMATED PATTERN RECOGNITION; BRAIN; BRAIN CIRCULATION; BRAIN NEOPLASMS; DIAGNOSTIC USE; IMAGE PROCESSING; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCINTISCANNING; SURGERY; YOUNG ADULT;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CEREBROVASCULAR CIRCULATION; FEMALE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM GRADING; PATTERN RECOGNITION, AUTOMATED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 84885025556     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1178-3     Document Type: Article

References (39)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109. doi: 10.1007/s00401-007- 0243-4
2. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129-3140
3. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO*task force. Eur J Neurol 17:1124-1133. doi: 10.1111/j.1468-1331.2010.03151.x
4. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC Jr, Capelle L (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53:524-528. doi: 10.1002/ana.10528
5. Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727-733. doi: 10.1002/ana.22106
6. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421-430. doi: 10.1016/S1474-4422(07)70103-5
7. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C, Karim AB (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084
8. Pallud J, Taillandier L, Capelle L, Fontaine D, Peyre M, Ducray F, Duffau H, Mandonnet E (2012) Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates. Neurosurgery 71:729-739. doi: 10.1227/NEU.0b013e31826213de discussion 739-740
9. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
10. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, Yamada R (2001) The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22:1081-1088
11. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y, Takahashi M (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53-60. doi: 10.1002/(SICI)1522- 2586(199901)9
12. Price SJ (2007) The role of advanced MR imaging in understanding brain tumour pathology. Br J Neurosurg 21:562-575. doi: 10.1080/02688690701700935
13. Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9:906-920. doi: 10.1016/S1474-4422(10)70181-2
14. Smits A, Baumert BG (2011) The clinical value of PET with amino acid tracers for gliomas WHO grade II. Int J Mol Imaging 2011:372509. doi: 10.1155/2011/372509
15. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R (1998) "Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 18:500-509. doi: 10.1097/00004647-199805000- 00005
16. la Fougere C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC (2011) Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol 13:806-819. doi: 10.1093/neuonc/nor054
17. 11C]d-glucose, and [68 Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9:683-689
18. 11C-Methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316-1322
19. 11C]l-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 10:7163-7170. doi: 10.1158/1078-0432.CCR-04-0262
20. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H, Bergstrom M, Smits A (2001) Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92:1541-1549. doi: 10.1002/1097-0142(20010915)92
21. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
22. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867
23. Wu O, Ostergaard L, Sorensen AG (2005) Technical aspects of perfusion-weighted imaging. Neuroimaging Clin N Am xi:623-637. doi: 10.1016/j.nic.2005.08.009
24. Vrabec M, Van Cauter S, Himmelreich U, Van Gool SW, Sunaert S, De Vleeschouwer S, Suput D, Demaerel P (2011) MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study. Neuroradiology 53:721-731. doi: 10.1007/s00234-010-0802-6
25. Alyafei S, Inoue T, Zhang H, Ahmed K, Oriuchi N, Sato N, Suzuki H, Endo K (1999) Image fusion system using PACS for MRI, CT, and PET images. Clin Positron Imaging 2:137-143
26. Cizek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD (2004) Fast and robust registration of PET and MR images of human brain. Neuroimage 22:434-442. doi: 10.1016/j.neuroimage.2004.01.016
27. Lilja A, Bergstrom K, Hartvig P, Spannare B, Halldin C, Lundqvist H, Langstrom B (1985) Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography. AJNR Am J Neuroradiol 6:505-514
28. 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32:39-51. doi: 10.1007/s00259-004-1564-3
29. Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nister M, Smits A, Ren ZP (2007) Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Acta Neuropathol 113:129-136. doi: 10.1007/s00401-006-0142-0
30. Murakami R, Hirai T, Sugahara T, Fukuoka H, Toya R, Nishimura S, Kitajima M, Okuda T, Nakamura H, Oya N, Kuratsu J, Yamashita Y (2009) Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one-versus two-parameter pilot method. Radiology 251:838-845. doi: 10.1148/radiol.2513080899
31. Sadeghi N, Salmon I, Tang BN, Denolin V, Levivier M, Wikler D, Rorive S, Baleriaux D, Metens T, Goldman S (2006) Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. J Magn Reson Imaging 24:989-994. doi: 10.1002/jmri.20757
32. Caseiras GB, Thornton JS, Yousry T, Benton C, Rees J, Waldman AD, Jager HR (2008) Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference? AJNR Am J Neuroradiol 29:1140-1141. doi: 10.3174/ajnr.A0993
33. Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536. doi: 10.3171/jns.1993.79.4.0533
34. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947-949
35. Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G (2008) Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247:490-498. doi: 10.1148/radiol.2472070898
36. Jenkinson MD, Smith TS, Joyce KA, Fildes D, Broome J, du Plessis DG, Haylock B, Husband DJ, Warnke PC, Walker C (2006) Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours. Neuroradiology 48:703-713. doi: 10.1007/s00234-006-0122-z
37. Thomsen H, Steffensen E, Larsson EM (2012) Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Acta Radiol 53:95-101. doi: 10.1258/ar.2011.110242
38. Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K (2008) Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol 29:1872-1877. doi: 10.3174/ajnr.A1254
39. Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S (2011) MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol 13:447-455. doi: 10.1093/neuonc/noq197